---
title: "BPC-157"
slug: "bpc-157"
type: "compound"
category: "Recovery"
url: "https://peptidesciencethailand.com/compounds/bpc-157"
description: "BPC-157 for tendon, gut, and ligament repair: mechanism of action, published dosing ranges, and what the research actually shows. Independent compound profile."
---
# BPC-157

*Body Protection Compound, Accelerating Tissue Repair at the Molecular Level*

**Category:** Recovery  
**Format:** Lyophilized Vial  
**Amount:** 5mg  
**Purity:** >99.5% (HPLC)

## Overview

BPC-157, formally known as Body Protection Compound-157, is a synthetic pentadecapeptide consisting of 15 amino acids with the sequence Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val. It is derived from a protective protein found in human gastric juice, known as BPC, which plays a fundamental role in maintaining and repairing the gastrointestinal tract. First isolated and characterized by researchers at the University of Zagreb in the early 1990s, BPC-157 has since become one of the most extensively studied cytoprotective peptides in preclinical research.

At the molecular level, BPC-157 operates through a notably complex and multi-targeted mechanism of action that distinguishes it from single-pathway therapeutic compounds. Its primary mechanism involves direct interaction with the vascular endothelial growth factor receptor 2 (VEGFR2) system, which plays a central role in angiogenesis, the formation of new blood vessels. By modulating VEGFR2 signaling, BPC-157 promotes the development of new vascular networks in damaged tissue, ensuring adequate blood supply for repair processes. This pro-angiogenic activity has been demonstrated in multiple animal models involving tendon, ligament, muscle, and bone injuries.

Beyond its vascular effects, BPC-157 activates the PI3K/Akt signaling pathway, a critical intracellular cascade involved in cell survival, proliferation, and migration. This activation leads to downstream stimulation of endothelial nitric oxide synthase (eNOS), increasing nitric oxide production. Nitric oxide serves as a vasodilator and anti-inflammatory mediator, improving local blood flow and reducing tissue swelling at injury sites. The peptide also modulates the FAK-paxillin pathway, which governs cell adhesion and migration, essential processes for wound closure and tissue remodeling.

Research has consistently demonstrated BPC-157's ability to upregulate growth hormone receptor expression in injured tissue, amplifying the local effects of circulating growth hormone without increasing systemic GH levels. Studies published in the Journal of Physiology-Paris and the Journal of Orthopaedic Research have documented accelerated healing of transected Achilles tendons, crushed muscles, and damaged ligaments in animal models. The peptide has also shown cytoprotective effects against various toxic insults, including alcohol, NSAIDs, and stress-induced gastric lesions, reflecting its origins as a gastric protective factor.

BPC-157 exhibits additional neuroprotective properties through modulation of the dopaminergic and serotonergic systems. Research has shown it can counteract dopamine system dysfunction and has been studied in models of traumatic brain injury, where it demonstrated reduced lesion volume and improved functional outcomes. Its interaction with the nitric oxide system extends to neuroprotection, as NO-mediated signaling plays key roles in both peripheral tissue repair and central nervous system function.

specialist oversight is particularly important when considering BPC-157, as its interaction with the vascular system means it may influence blood pressure regulation and could potentially interact with anticoagulant medications or blood pressure treatments. Individual assessment of cardiovascular status, medication history, and specific injury type helps ensure the compound is used appropriately within a comprehensive treatment protocol.

## Mechanism of Action

### Step 1: VEGFR2 Receptor Binding

BPC-157 interacts with the vascular endothelial growth factor receptor 2 (VEGFR2), initiating the signaling cascade that drives new blood vessel formation in damaged tissue regions.

### Step 2: PI3K/Akt Pathway Activation

VEGFR2 engagement triggers the phosphoinositide 3-kinase (PI3K) and protein kinase B (Akt) pathway, promoting cell survival signals that protect existing tissue and stimulate cellular proliferation.

### Step 3: eNOS Stimulation & NO Production

Akt pathway activation stimulates endothelial nitric oxide synthase (eNOS), increasing local nitric oxide production. NO acts as a potent vasodilator and anti-inflammatory mediator at the injury site.

### Step 4: Angiogenesis & Tissue Repair

Enhanced blood vessel formation delivers oxygen, nutrients, and growth factors to damaged tissue. BPC-157 simultaneously activates the FAK-paxillin pathway, governing cell migration into wound sites.

### Step 5: Growth Factor Receptor Upregulation

BPC-157 upregulates growth hormone receptor expression locally in injured tissue, amplifying the healing effects of circulating growth factors without elevating systemic hormone levels.

## Researched Benefits

### Accelerated Tissue Healing

BPC-157 has demonstrated significant acceleration of healing in tendons, ligaments, muscles, and bones across numerous preclinical studies. Its multi-targeted mechanism addresses both structural repair and the inflammatory microenvironment, resulting in faster recovery timelines and improved tissue quality.

### Gastric Cytoprotection

Derived from gastric juice proteins, BPC-157 exhibits powerful protective effects on the gastrointestinal mucosa. Research shows it can counteract damage from NSAIDs, alcohol, and stress-induced lesions, supporting gut integrity and function through enhanced mucosal blood flow and epithelial regeneration.

### Anti-Inflammatory Action

Through nitric oxide modulation and vascular regulation, BPC-157 reduces localized inflammation without the immunosuppressive effects associated with corticosteroids. This targeted anti-inflammatory activity helps create an optimal healing environment while preserving necessary immune function.

### Neuroprotective Properties

BPC-157 modulates dopaminergic and serotonergic pathways, demonstrating neuroprotective effects in preclinical models of traumatic brain injury and neurotoxicity. Research suggests it may help maintain neurological function and support nervous system recovery following injury.

## Dosage & Administration

| Parameter | Detail |
| --- | --- |
| Protocol | 250-500mcg per day, administered subcutaneously near the injury site or abdominally for systemic effects |
| Route | Subcutaneous injection |
| Duration | 4-6 weeks per cycle |
| Cycle Notes | Many protocols incorporate a 2-4 week rest period between cycles. Loading phases of 500mcg daily may be used for the first 1-2 weeks before reducing to 250mcg maintenance. |
| Reconstitution | Reconstitute with bacteriostatic water. Using a 5mg vial with 2mL bacteriostatic water yields 2500mcg/mL concentration. Store reconstituted solution refrigerated at 2-8°C and use within 28 days. |

> **Specialist note:** A your specialist will determine the optimal dosage based on the injury type, severity, location, body weight, and concurrent medications. Individuals taking anticoagulants or blood pressure medications require adjusted protocols due to BPC-157's effects on the vascular system.

## Compound Reference Data

| Property | Value |
| --- | --- |
| Format | Lyophilized Powder |
| Amount | 5mg per vial |
| Purity | >99.5% |
| Purity Method | HPLC (High-Performance Liquid Chromatography) |
| Sequence | Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val |
| Molecular Weight | 1419.53 g/mol |
| Storage | Store lyophilized powder at -20°C. Reconstituted solution at 2-8°C. Protect from light. |
| Appearance | White to off-white lyophilized powder |

## Medical Guidance

BPC-157 interacts with vascular growth factor pathways and nitric oxide signaling, which means it can influence blood pressure regulation and vascular tone. Patients taking blood pressure medications, anticoagulants, or those with cardiovascular conditions require careful specialist assessment before initiating a BPC-157 protocol. Additionally, its growth-factor-promoting properties mean screening for certain pre-existing conditions is essential.

## Frequently Asked Questions

### What is BPC-157 and how does it work?

BPC-157 is a 15-amino acid synthetic peptide derived from a protective protein found naturally in human gastric juice. It works through multiple cellular pathways, primarily by activating the VEGFR2 receptor to promote angiogenesis (new blood vessel formation), stimulating the PI3K/Akt pathway for cell survival, and increasing nitric oxide production for anti-inflammatory and vasodilatory effects. This multi-targeted mechanism accelerates tissue healing across tendons, ligaments, muscles, and the gastrointestinal tract.

### What medical guidance applies to BPC-157?

BPC-157 is a compound studied in clinical research that should only be used under qualified medical supervision. A specialist consultation helps ensure your dosage, injection site protocol, cycle duration, and monitoring plan are optimized for individual biology, specific injury type, medical history, and concurrent medications. This is essential for both safety and informed decision-making, particularly given BPC-157's interactions with the vascular and nitric oxide systems.

### What conditions has BPC-157 been studied for in research?

Preclinical research has investigated BPC-157 for tendon and ligament injuries, muscle tears, bone fractures, gastric ulcers, inflammatory bowel conditions, nerve damage, and traumatic brain injury. Studies published in journals including the Journal of Orthopaedic Research and the Journal of Physiology-Paris have demonstrated significant healing acceleration across these tissue types. All research to date has been preclinical, and human clinical trials are ongoing.

### How should BPC-157 be stored and reconstituted?

Store lyophilized (freeze-dried) BPC-157 at -20°C protected from light. For reconstitution, slowly add bacteriostatic water along the vial wall to avoid damaging the peptide. A common preparation uses 2mL of bacteriostatic water with a 5mg vial, yielding 2500mcg/mL. Once reconstituted, store at 2-8°C (standard refrigerator) and use within 28 days. Never freeze reconstituted peptide solution.

### Can BPC-157 be combined with other peptides?

Many research protocols investigate BPC-157 in combination with TB-500 (Thymosin Beta-4) for enhanced recovery outcomes, as the two peptides work through complementary mechanisms. BPC-157 promotes angiogenesis via VEGFR2 while TB-500 facilitates cell migration via actin regulation. However, any combination protocol must be designed and monitored by a your specialist, who will assess specific needs, potential interactions, and appropriate dosing for stacked protocols.

## References

1. **Emerging Use of BPC-157 in Orthopaedic Sports Medicine: A Systematic Review** — HSS Journal — 2025
2. **Intra-Articular Injection of BPC 157 for Multiple Types of Knee Pain** — Alternative Therapies in Health and Medicine — 2021
3. **Multifunctionality and Possible Medical Application of the BPC 157 Peptide: Literature and Patent Review** — Pharmaceuticals — 2025

## Related Compounds

- /compounds/tb-500
- /compounds/ghk-cu
- /compounds/cjc-1295-ipamorelin

## Comparisons

- /compare/bpc-157-vs-tb-500